caus
ten
thousand
infect
one
thousand
death
current
regist
therapi
treat
coronaviru
infect
time
consum
process
new
drug
develop
drug
reposit
may
solut
epidem
sudden
infecti
diseas
systemat
analyz
protein
encod
gene
compar
protein
coronavirus
predict
structur
built
structur
could
done
homolog
model
perform
targetbas
virtual
ligand
screen
total
target
includ
two
human
target
screen
compound
librari
includ
zinc
drug
databas
databas
natur
product
structur
screen
result
import
target
proteas
spike
rnadepend
rna
polymeras
rdrp
abbrevi
proteas
e
envelop
membran
protein
n
nucleocapsid
protein
nsp
nonstructur
protein
orf
open
read
frame
pdb
protein
data
bank
rdrp
rnadepend
rna
polymeras
spike
sud
sar
uniqu
domain
ub
ubiquitinlik
domain
pleas
cite
articl
wu
canrong
et
al
analysi
therapeut
target
discoveri
potenti
drug
comput
method
acta
pharmaceutica
sinica
b
http
doi
coronavirus
cov
caus
major
outbreak
human
fatal
pneumonia
sinc
begin
centuri
sever
acut
respiratori
syndrom
coronaviru
sarscov
broke
spread
five
contin
lethal
rate
middl
east
respiratori
syndrom
coronaviru
merscov
broke
arabian
peninsula
fatal
rate
sarscov
merscov
zoonot
virus
host
batcivet
dromedari
respect
date
specif
therapeut
drug
vaccin
approv
treatment
human
coronaviru
therefor
cov
consid
kind
virus
outbreak
pose
huge
threat
human
novel
coronaviru
found
end
name
novel
coronaviru
world
health
organ
januari
sinc
highli
homolog
sarscov
consid
close
rel
sarscov
intern
viru
classif
commiss
ictv
classifi
sever
acut
respiratori
syndrom
coronaviru
februari
time
name
diseas
caus
common
symptom
person
infect
coronaviru
includ
respiratori
symptom
fever
cough
short
breath
dyspnea
sever
case
infect
caus
pneumonia
sever
acut
respiratori
syndrom
kidney
failur
even
death
current
specif
medicin
treatment
diseas
caus
cov
envelop
virus
posit
rna
genom
belong
coronavirida
famili
order
nidoviral
divid
four
genera
b
g
belong
b
genu
cov
contain
least
four
structur
protein
spike
protein
envelop
e
protein
membran
protein
nucleocapsid
n
protein
among
spike
promot
host
attach
virusecel
membran
fusion
viru
infect
therefor
spike
determin
extent
host
rang
potenti
anticoronaviru
therapi
divid
two
categori
depend
target
one
act
human
immun
system
human
cell
coronaviru
term
human
immun
system
innat
immun
system
respons
play
import
role
control
replic
infect
coronaviru
interferon
expect
enhanc
immun
respons
block
signal
pathway
human
cell
requir
viru
replic
may
show
certain
antivir
effect
addit
virus
often
bind
receptor
protein
surfac
cell
order
enter
human
cell
exampl
sar
viru
bind
angiotensinconvert
enzym
receptor
mer
bind
receptor
therapi
act
coronaviru
includ
prevent
synthesi
viral
rna
act
genet
materi
viru
inhibit
viru
replic
act
critic
enzym
viru
block
viru
bind
human
cell
receptor
inhibit
viru
selfassembl
process
act
structur
protein
fight
coronaviru
scientist
come
three
strategi
develop
new
drug
first
strategi
test
exist
broadspectrum
antivir
interferon
ribavirin
cyclophilin
inhibitor
use
treat
coronaviru
pneumonia
fall
categori
advantag
therapi
metabol
characterist
dosag
use
potenti
efficaci
side
effect
clear
approv
treat
viral
infect
disadvantag
therapi
broadspectrum
kill
coronavirus
target
manner
side
effect
underestim
second
strategi
use
exist
molecular
databas
screen
molecul
may
therapeut
effect
coronaviru
highthroughput
screen
make
strategi
possibl
new
function
mani
drug
molecul
found
strategi
exampl
discoveri
antihiv
infect
drug
lopinavirritonavir
third
strategi
directli
base
genom
inform
patholog
characterist
differ
coronavirus
develop
new
target
drug
scratch
theoret
drug
found
therapi
would
exhibit
better
anticoronaviru
effect
research
procedur
new
drug
might
cost
sever
year
even
year
develop
medicin
treat
fastest
way
find
potenti
molecul
market
drug
efficaci
determin
approv
green
channel
approv
hospit
ethic
committe
rapid
clinic
treatment
patient
herein
bioinformat
analysi
protein
encod
novel
coronaviru
gene
systemat
conduct
protein
compar
coronavirus
sarscov
merscov
conduct
homolog
model
build
possibl
protein
structur
includ
viral
papain
like
proteas
plpro
main
proteas
also
name
proteas
rnadepend
rna
polymeras
rdrp
helicas
spike
etc
use
protein
human
rel
protein
human
typeii
transmembran
serin
proteas
enzym
target
screen
zinc
u
food
drug
administr
fda
approv
drug
databas
zinc
drug
databas
zdd
databas
tradit
chines
medicin
natur
product
includ
report
common
antivir
compon
tradit
chines
medicin
databas
commonli
use
antivir
drug
compound
virtual
ligand
screen
method
studi
predict
varieti
compound
may
inhibit
novel
coronavirus
provid
scientist
inform
compound
may
effect
subsequ
valid
antivir
effect
vitro
vivo
provid
use
inform
clinic
treatment
novel
coronaviru
pneumonia
complet
genom
download
ncbi
nucleotid
databas
thenucleotid
sequenc
align
whole
databas
use
blastn
search
homolog
viral
genom
alogorithm
paramet
max
target
sequenc
expect
threshold
nucleotid
sequenc
edit
conduct
use
bioedit
dnaman
sequenc
align
conduct
use
dnaman
clustaiw
evolutionari
histori
infer
use
neighborjoin
method
mega
seven
softwar
packag
percentag
replic
tree
associ
taxa
cluster
togeth
bootstrap
test
determin
replic
protein
sequenc
manag
analysi
carri
use
snap
gene
view
sequenc
align
perform
use
clustalw
method
jalview
softwar
second
structur
protein
sequenc
predict
homolog
model
predict
carri
search
databas
includ
fold
function
assign
system
ffasgodziklaborg
predict
transmembran
helic
protein
carri
tmhmm
server
v
onlin
http
wwwcbsdtudkservicestmhmm
structur
structur
align
pymol
structur
align
tool
approv
drug
databas
subset
zinc
databas
zdd
zinc
drug
databas
contain
compound
natur
product
databas
construct
contain
chemic
separ
tradit
chines
herbal
laboratori
natur
occur
potenti
antivir
compon
deriv
antivir
compound
librari
contain
known
antivir
drug
report
antivir
compound
literatur
search
correspond
homolog
model
predict
fold
function
assign
system
server
target
protein
download
protein
data
bank
wwwrcsborg
align
two
protein
sequenc
subsequ
homolog
model
perform
bioinformat
modul
icm
model
softwar
intel
processor
molsoft
llc
san
diego
ca
usa
structurebas
virtual
screen
ligand
continu
resili
made
dock
target
repres
potenti
energi
map
icm
softwar
identifi
possibl
drug
candid
compound
databas
score
accord
intern
coordin
mechan
intern
coordin
mechan
icm
base
mont
carlo
method
stochast
global
optim
procedur
pseudobrownian
positionaltorsion
step
posit
intrins
molecular
optim
visual
inspect
compound
outsid
activ
site
well
weakli
fit
activ
site
elimin
compound
score
less
mfscore
less
gener
repres
strong
interact
prioriti
select
proteineprotein
dock
follow
manual
icm
softwar
obtain
genom
gene
bank
genom
sequenc
align
whole
databas
use
blastn
search
homolog
viral
genom
phylogenet
analysi
sequenc
align
coronavirus
variou
speci
found
three
coronavirus
bat
batcov
respect
highest
genom
sequenc
ident
fig
moreov
shown
fig
batcov
exhibit
closest
linkag
among
coronavirus
human
sarscov
exhibit
highest
genom
sequenc
ident
mersisol
also
ident
sarscov
clearli
studi
one
among
virus
accord
previou
literatur
structur
function
genom
encod
protein
elucid
recent
year
studi
high
genom
ident
sarscov
structur
function
predict
genom
encod
protein
mainli
base
research
homolog
protein
sarscov
genom
open
read
frame
fig
encod
replicas
polyprotein
ab
cleav
two
proteas
replicas
protein
show
multifunct
involv
transcript
replic
viral
rna
encod
viral
structur
protein
n
e
protein
auxiliari
protein
e
protein
involv
format
viral
coat
n
protein
involv
packag
rna
genom
fig
align
amino
acid
sequenc
sar
analyz
characterist
restrict
cleavag
site
recogn
plpro
specul
specif
proteolyt
site
plpro
fig
plpro
cleav
three
site
nterminu
cut
site
cterminu
form
nonstructur
protein
among
contain
multipl
domain
includ
segment
sar
uniqu
domain
deubiquitin
proteolyt
enzym
plpro
rdrp
analysi
therapeut
target
helicas
new
coronaviru
structur
biolog
studi
protein
still
earli
stage
one
crystal
structur
deposit
pdb
pdb
code
order
acquir
threedimension
structur
inform
protein
new
coronavirus
subsequ
drug
screen
align
protein
sequenc
sequenc
databas
fold
function
assign
system
support
inform
fig
fortun
protein
found
high
homolog
protein
threedimension
structur
homolog
support
inform
tabl
pdb
code
label
correspond
sequenc
fig
unsurprisingli
protein
highest
homolog
sar
nevertheless
protein
still
high
homolog
databas
predict
transmembran
helic
protein
carri
tmhmm
server
expect
found
protein
transmembran
protein
except
support
inform
fig
far
found
much
structur
inform
viral
protein
possibl
provid
basi
subsequ
homolog
model
drug
screen
homolog
model
protein
sequenc
align
model
sequenc
deriv
sarscov
predict
secondari
structur
time
fig
tabl
interestingli
shown
fig
import
antiviru
drug
target
protein
like
plpro
rdrp
highli
conserv
two
human
coronavirus
especi
function
region
shown
tabl
potenti
drug
target
protein
homolog
model
gener
protein
model
provid
pdb
file
support
inform
coordin
targetscreen
hit
complex
provid
upon
request
order
verifi
accuraci
homolog
model
align
comput
structur
model
sarscov
crystal
structur
solv
releas
manuscript
prepar
comput
model
show
ca
rmsd
overal
structur
compar
structur
fig
ca
rmsd
substrat
bind
region
show
subtl
differ
molecul
known
human
entri
receptor
spike
facilit
crossspeci
transmiss
sequenc
align
result
show
homolog
spikereceptor
bind
domain
rbd
sequenc
sarscov
fig
recent
research
specul
could
also
bind
verifi
comput
dock
elisa
measur
moreov
homolog
spikerbd
sequenc
batcov
high
despit
high
homolog
spike
sequenc
analysi
found
four
among
five
import
amino
acid
bind
batcov
differ
fig
relat
research
literatur
whether
batcov
infect
human
yet
also
perform
homolog
model
batcov
spike
rbd
support
inform
fig
three
spike
rbd
structur
dock
human
among
conform
resembl
crystal
structur
sar
complex
bind
free
energi
spike
rbd
human
kcalmol
support
inform
fig
sarscov
spike
rbd
kcalmol
support
inform
fig
batcov
spike
rbd
kcalmol
support
inform
fig
therapi
act
coronaviru
divid
sever
categori
base
specif
pathway
act
enzym
function
protein
critic
viru
prevent
viru
rna
synthesi
replic
act
structur
protein
viru
block
viru
bind
human
cell
receptor
inhibit
viru
selfassembl
process
produc
virul
factor
restor
host
innat
immun
act
host
specif
receptor
enzym
prevent
viru
enter
host
cell
relat
target
protein
includ
plpro
complex
echannel
e
protein
spike
ctermin
rna
bind
domain
crbd
ntermin
rna
bind
domain
nrbd
helicas
rdrp
base
homolog
model
viral
protein
model
two
human
target
resort
structurebas
virtual
ligand
screen
method
use
icm
model
softwar
molsoft
llc
screen
potenti
smallmolecul
compound
zinc
drug
databas
compound
small
inhous
databas
tradit
chines
medicin
natur
product
includ
report
common
antivir
compon
tradit
chines
medicin
deriv
compound
compound
lower
calcul
bind
energi
express
score
mfscore
consid
higher
bind
affin
target
protein
signific
function
protein
coronaviru
nsp
involv
rna
transcript
translat
protein
synthesi
plpro
respons
cleavag
nterminu
replicas
polyprotein
releas
essenti
correct
viru
replic
plpro
also
confirm
signific
antagon
host
innat
immun
indispens
enzym
process
coronaviru
replic
infect
host
plpro
popular
target
coronaviru
inhibitor
valuabl
target
plpro
treat
coronaviru
infect
inhibitor
approv
fda
market
screen
result
tabl
support
excel
file
plproxlsx
show
seri
antiviru
drug
ribavirin
valganciclovir
thymidin
antibacteri
drug
chloramphenicol
cefamandol
tigecyclin
muscl
relax
drug
chlorphenesin
carbam
antituss
drug
levodropropizin
may
high
bind
affin
plpro
natur
product
tabl
support
excel
file
plpronpxlsx
platycodin
platycodon
grandifloru
baicalin
scutellaria
baicalensi
cyperu
rotundu
phaitanthrin
isati
indigotica
catechin
compound
e
epigallocatechin
gallat
exhibit
high
bind
affin
plpro
protein
suggest
potenti
util
compound
treatment
antivir
drug
ribavirin
predict
bind
plpro
low
bind
energi
score
z
gener
dock
model
ribavirin
bound
activ
site
enzym
report
sarsplpro
inhibitor
pdb
code
hydrogen
bond
predict
compound
also
pep
stack
found
triazol
compound
fig
b
strong
hydrogen
bond
hydrophob
interact
ribavirin
enzym
impli
may
potent
plpro
inhibitor
also
known
first
automat
cleav
polyprotein
produc
matur
enzym
cleav
downstream
nsp
site
releas
directli
mediat
matur
nsp
essenti
life
cycl
viru
detail
investig
structur
catalyt
mechan
make
attract
target
anticoronaviru
drug
develop
inhibitor
target
sarscov
mainli
includ
peptid
inhibitor
smallmolecul
inhibitor
monom
three
domain
domain
residu
domain
ii
residu
domain
iii
residu
long
loop
residu
connect
domain
ii
iii
activ
site
locat
gap
domain
ii
cyshi
catalyt
dyad
shown
tabl
support
excel
file
antibacteri
drug
lymecyclin
demeclocyclin
doxycyclin
oxytetracyclin
antihypertens
drug
nicardipin
telmisartan
conivaptan
treat
hyponatremia
show
highest
bind
affin
sever
natur
compound
deriv
antiviru
antiinflammatori
effect
also
exhibit
high
bind
affin
tabl
support
excel
file
includ
seri
andrographolid
deriv
baicalensi
betulon
cassin
xylocarpa
acid
isodecortinol
cerevisterol
viola
diffusa
hesperidin
neohesperidin
citru
aurantium
kouitchensid
deacetylcentapicrin
plant
swertia
genu
result
suggest
smallmolecul
compound
might
potenti
inhibitor
could
probabl
use
treat
worth
mention
antiasthmat
drug
montelukast
also
show
low
bind
energi
shown
fig
montelukast
well
fit
activ
pocket
lot
hydrophob
amino
acid
like
compos
rel
hydrophob
environ
contain
compound
stabil
conform
hydrogen
bond
predict
carbonyl
group
compound
fig
conserv
protein
coronaviru
rnadepend
rna
polymeras
rdrp
vital
enzym
coronaviru
replicationtranscript
complex
rdrp
domain
polymeras
locat
cterminu
conserv
seraspasp
motif
de
novo
synthes
six
nucleotid
length
use
primer
rna
synthesi
complex
increas
bind
rna
enhanc
rdrp
enzym
activ
research
sarscov
merscov
inhibitor
use
import
drug
target
principl
target
inhibit
could
caus
signific
toxic
side
effect
host
cell
specif
inhibitor
found
virtualscreeningresultsofrdrpdemonstratedsomedrugsmightb
potentialinhibitorswith
suchasseveralantifung
drug
itraconazol
antibacteri
drug
novobiocin
gallstonedissolv
drug
chenodeoxychol
acid
antiallerg
drug
cortison
antitumor
drug
idarubicin
hepatoprotect
drug
silybin
muscl
relax
drug
pancuronium
bromid
chronic
enter
anticoagul
drug
dabigatran
etexil
tabl
support
excel
file
rdrpxlsx
natur
product
deriv
antiviru
antiinflamm
antitumor
effect
exhibit
high
bind
affin
rdrp
betulon
c
xylocarpa
gnidicin
gniditrin
gnidia
lamprantha
v
diffusa
andrographi
paniculata
swerti
apseudochinensi
theaflavin
diogal
camellia
sinensi
andrographolid
deriv
r
e
ethenyl
c
therapeut
target
yl
methyl
tabl
support
excel
file
rdrpnpxlsx
helicas
multifunct
protein
includ
ntermin
metal
bind
domain
mbd
helicas
domain
hel
ntermin
structur
contain
cystein
residu
form
zn
bind
domain
helicas
domain
conserv
motif
cterminu
unravel
doublestrand
ds
dna
rna
along
direct
ntpdepend
manner
importantli
report
sequenc
conserv
indispens
necessari
compon
replic
coronaviru
therefor
identifi
target
antivir
drug
discoveri
report
inhibitor
base
structur
model
helicas
protein
antibacteri
drug
lymecyclin
cefsulodin
rolitetracyclin
antifung
drug
itraconazol
antihuman
immunodefici
drug
saquinavir
anticoagul
drug
dabigatran
diuret
drug
canreno
acid
predict
helicas
inhibitor
high
mfscore
virtual
ligand
screen
natur
product
mani
flavanoid
differ
sourc
aglucosyl
hesperidin
hesperidin
rutin
besid
target
nonstructur
protein
includ
complex
also
play
import
role
viru
rna
synthesi
replic
suggest
protein
may
use
target
antivir
drug
discoveri
virtual
screen
result
show
mani
antibacteri
antivir
antiinflammatori
drug
zinc
drug
databas
inhous
natur
productsderiv
databas
display
potenti
good
affin
target
detail
inform
virtual
screen
result
shown
support
excel
file
zdd
screen
result
file
name
targetxlsx
natur
product
screen
result
file
name
targetnpxlsx
spike
main
structur
protein
coronaviru
assembl
special
corolla
structur
surfac
viru
trimer
spike
main
protein
interact
host
bind
host
cell
receptor
mediat
viru
invas
determin
viral
tissu
host
tropism
spike
cleav
host
cell
proteas
like
etc
main
function
bind
host
cell
surfac
receptor
subunit
mediat
virusecel
cellecel
membran
fusion
spike
structur
integr
cleavag
activ
play
key
role
viru
invas
virul
therapeut
strategi
block
coronaviru
enter
host
cell
target
spike
protein
specif
receptor
host
surfac
valuabl
develop
antivir
drug
basi
virtual
screen
result
smallmolecul
compound
spike
protein
drug
show
high
analysi
therapeut
target
model
bind
affin
mfscore
score
antihypertens
drug
rescinnamin
iloprost
prazosin
antifung
drug
posaconazol
itraconazol
antibacteri
drug
sulfasalazin
azlocillin
penicillin
cefsulodin
anticoagul
drug
dabigatran
etexil
natur
flavanoid
licoflavonol
glycyrrhiza
uralensi
cosmosiin
baicalensi
neohesperidin
c
aurantium
mangostin
garcinia
mangostana
kouitchensid
swertia
kouitchensi
excoecariatoxin
excoecaria
agallocha
phyllaemblicin
p
emblica
piceatannol
viti
vinifera
exhibit
high
bind
affin
detail
virtual
screen
result
shown
support
excel
file
howev
compound
predict
bind
bind
interfac
complex
compound
could
target
bind
interfac
spike
hesperidin
shown
fig
hesperidin
predict
lie
middl
shallow
pit
surfac
rbd
spike
dihydroflavon
part
compound
went
parallel
sheet
rbd
sugar
part
insert
shallow
pit
direct
away
hydrophob
amino
acid
includ
form
rel
hydrophob
shallow
pocket
contain
compound
fig
hydrogen
bond
predict
compound
superimpos
complex
hesperidinerbd
complex
distinct
overlap
hesperidin
interfac
could
observ
fig
suggest
hesperidin
may
disrupt
interact
rbd
except
spike
protein
e
protein
echannel
possess
import
biolog
function
structur
integr
coronaviru
host
virul
nrbd
crbd
coronaviru
n
protein
need
n
protein
host
cell
bind
coronaviru
rna
effici
therefor
e
protein
n
protein
nrbd
crbd
domain
use
target
discoveri
antivir
drug
virtual
screen
mani
antibacteri
antivir
antitumor
antiasthmat
antiinflammatori
drug
etc
zinc
databas
inhous
natur
productsderiv
databas
found
display
rel
good
affin
target
detail
result
virtual
screen
given
supplementari
excel
file
three
coronaviru
virul
factor
relat
interf
host
innat
immun
assist
also
inhibit
typei
interferon
product
abil
bind
host
adpribos
help
coronaviru
resist
host
innat
immun
bone
marrow
matrix
antigen
inhibit
releas
newlyassembl
coronaviru
host
cell
sarscov
directli
bind
inhibit
activ
block
glycosyl
evid
suggest
may
potenti
target
antivir
drug
discoveri
detail
screen
result
show
seri
clinic
drug
natur
product
antibacteri
antiinflammatori
effect
exhibit
rel
high
bind
affin
three
target
protein
piperacillin
cefpiramid
streptomycin
lymecyclin
tetracyclin
platycodin
platycodon
grandiflora
wogonosid
baicalensi
vitexin
vitex
negundo
andrographolid
deriv
xanthon
swertia
genu
detail
result
virtual
screen
shown
support
excel
file
host
prove
mani
studi
specif
receptor
spike
rbd
sarscov
latest
research
show
host
receptor
consist
sarscov
exhibit
spike
rbd
sequenc
similar
sarscov
rbd
import
interact
sever
key
amino
acid
residu
rbd
receptorbind
motif
base
current
research
progress
consid
host
target
treatment
coronaviru
infect
block
enter
host
cell
base
virtual
screen
result
protein
antidiabet
drug
troglitazon
antihypertens
drug
losartan
analgesia
drug
ergotamin
antibacteri
drug
cefmenoxim
hepatoprotect
drug
silybin
etc
predict
bind
low
energi
natur
product
phyllaemblicin
p
emblica
xanthon
plant
swertia
genu
neohesperidin
hesperidin
c
aurantium
exhibit
potenti
high
bind
affin
protein
howev
none
bind
compound
predict
target
interfac
addit
known
cut
spike
trigger
infect
sarscov
merscov
studi
shown
inhibit
enzym
activ
prevent
coronavirus
enter
host
cell
possibl
target
antivir
drug
discoveri
virtual
screen
result
shown
support
excel
file
predict
mani
antibacteri
drug
pivampicillin
hetacillin
cefoperazon
clindamycin
antiviru
natur
compound
phyllaemblicin
neoandrographolid
kouitchensid
etc
potenti
inhibitor
order
verifi
screen
result
zinc
drug
databas
util
current
resourc
antivir
drug
immedi
construct
databas
antivir
drug
deep
calcul
includ
compound
alreadi
market
current
undergo
clinic
trial
treat
infect
compound
dock
construct
target
two
human
target
predict
possibl
target
also
search
possibl
bind
partner
certain
import
target
special
attent
paid
drug
current
clinic
trial
result
calcul
dock
score
list
support
excel
file
antiviralsvstargetsscor
signific
score
score
mfscore
highlight
brighten
yellow
remdesivir
nucleosid
analogu
rdrp
inhibitor
inhibit
viru
inhibit
synthesi
viral
nucleic
acid
yet
approv
market
countri
januari
year
new
england
journal
medicin
report
diagnosi
treatment
first
patient
unit
state
remdesivir
show
potenti
treatment
first
patient
novel
coronaviru
infect
vero
cell
ec
remdesivir
mmoll
select
index
si
greater
remdesivir
current
undergo
random
doubleblind
control
phase
iii
clinic
studi
china
molecular
dock
result
show
potenti
target
remdesivir
score
z
rdrp
mfscore
z
echannel
mfscore
z
score
z
mfscore
z
rdrp
gener
dock
model
remdesivir
could
bind
rnabind
channel
rdrp
bind
mode
site
highli
similar
coxsackieviru
rdrp
inhibitor
bind
pocket
remdesivir
bottom
rna
templat
channel
posit
acceptor
templat
nucleotid
fig
b
compound
well
fit
shape
pocket
form
three
hydrogen
bond
addit
hydrophob
interact
may
direct
favorit
conform
remdesivir
fig
interestingli
remdesivir
predict
bind
target
low
bind
energi
score
mfscore
shown
fig
remdesivir
bound
rel
positivelycharg
alloster
pocket
far
away
enzym
activ
center
form
two
hydrogen
bond
phosphat
group
compound
weak
hydrophob
interact
pyrrolotriazin
ring
remdesivir
side
chain
polar
amino
acid
may
stabil
compound
conform
fig
lopinavir
ritonavir
market
china
mainli
use
treat
infect
adult
children
year
age
vitro
studi
shown
lopinavir
ritonavir
inhibit
replic
merscov
sarscov
exert
antivir
effect
drug
list
recommend
drug
antivir
drug
section
new
coronaviru
infect
pneumonia
diagnosi
treatment
program
molecular
dock
result
show
ritonavir
possibl
target
echannel
mfscore
respect
lopinavir
possibl
target
helicas
nrbd
echannel
mfscore
respect
arbidol
broadspectrum
antivir
drug
mainli
treatment
upper
respiratori
tract
infect
caus
influenza
b
virus
etc
recent
year
mani
studi
proven
effect
sarscov
merscov
arbidol
hydrochlorid
block
viru
replic
inhibit
fusion
lipid
membran
viru
host
cell
compar
untreat
control
group
arbidol
effect
inhibit
coronaviru
time
concentr
mmoll
significantli
inhibit
viru
patholog
effect
cell
dock
result
arbidol
possibl
drug
target
new
coronaviru
show
may
interact
complex
echannel
spike
mfscore
respect
darunavir
proteas
inhibitor
select
inhibit
cleavag
hivencod
gagpol
polyprotein
viral
infect
cell
therebi
prevent
format
matur
infecti
viru
particl
concentr
mmoll
darunavir
significantli
inhibit
viru
replic
inhibit
effici
time
compar
untreat
group
dock
result
show
possibl
target
darunavir
plpro
echannel
spike
protein
mfscore
respect
favipiravir
broadspectrum
antivir
drug
use
treat
flu
shenzhen
health
commiss
initi
clinic
studi
use
favipiravir
treat
infect
score
favipiravir
dock
target
virtual
screen
rel
low
chloroquin
phosphat
use
treatment
malaria
sinc
later
rheumatoid
arthriti
chloroquin
report
earlier
studi
direct
antivir
effect
inhibit
flaviviru
retroviru
hiv
mani
coronavirus
recent
studi
show
ec
mmoll
si
greater
chloroquin
effect
inhibit
cell
level
effici
human
bodi
infect
yet
clinic
proven
chloroquin
phosphat
turn
chloroquin
bodi
play
therapeut
effect
dock
result
show
possibl
target
chloroquin
echannel
dock
mfscore
respect
also
perform
longitudin
analysi
drug
target
result
show
tenofovir
disoproxil
fumar
beclabuvir
may
bind
fewer
compound
predict
act
target
nrbd
crbd
show
select
antivir
drug
unlik
act
target
new
coronaviru
provid
meaning
refer
futur
research
target
complex
plpro
rdrp
helicas
echannel
spike
antivir
drug
predict
bind
especi
echannel
rdrp
plpro
indic
target
like
use
discoveri
therapeut
drug
known
antivir
focu
subsequ
research
progress
earli
preclin
stage
date
sar
viru
year
ago
current
emerg
coronavirus
futur
may
continu
pose
threat
global
public
health
therefor
find
broadspectrum
inhibitor
may
reduc
effect
human
coronaviru
infect
remain
challeng
research
focu
given
timeconsum
natur
antivir
drug
develop
registr
exist
treatment
diseas
may
fastest
treatment
option
emerg
infecti
diseas
drug
prepar
medic
suffici
experi
dosag
safeti
adm
situat
well
known
studi
base
result
bioinformat
analysi
homolog
structur
protein
one
human
protein
built
plu
human
structur
total
target
setup
high
throughput
virtual
ligand
screen
special
doubl
score
system
icmpro
soft
allow
us
evalu
dock
result
accur
score
icm
softwar
calcul
overal
empir
function
predict
physic
interact
while
mfscore
mean
forc
score
comput
knowledgebas
potenti
function
deriv
statist
ligandereceptor
complex
pdb
proteineprotein
dock
result
deduc
spike
protein
strong
bind
affin
human
although
weaker
sarscov
spike
protein
unexpectedli
batcov
spike
protein
slightli
weaker
bind
affin
compar
specul
viru
may
capabl
infect
human
directli
close
evolv
batcov
may
one
two
host
evolut
involv
publish
articl
directli
relat
intermedi
host
yet
accord
recent
research
paper
clinic
characterist
infect
spread
rapidli
humantohuman
transmiss
consist
observ
proteineprotein
dock
result
spike
rbd
human
previou
predict
howev
fast
grow
incid
pneumonia
relat
death
impli
weaker
bind
spike
human
compar
sar
spike
may
fulli
explain
current
situat
epidem
must
receptor
infect
facilit
mechan
human
host
spikerbd
may
take
lower
energi
bind
conform
differ
current
sarscov
spikerbd
conform
found
crystal
structur
probabl
induc
fit
need
investig
search
potenti
coronaviru
therapeut
drug
soon
possibl
first
screen
potenti
compound
zinc
drug
databas
compound
small
inhous
databas
natur
product
compound
seri
clinic
drug
natur
product
antivir
antibacteri
antiinflammatori
effect
exhibit
high
bind
affin
differ
target
protein
indic
potenti
util
treat
identifi
number
compound
might
antivir
activ
approv
drug
librari
antiviru
drug
ribavirin
valganciclovir
thymidin
antibacteri
drug
cefpiramid
sulfasalazin
phenethicillin
lymecyclin
demeclocyclin
doxycyclin
oxytetracyclin
tigecyclin
antiasthmat
drug
montelukast
fenoterol
reproterol
hepatoprotect
drug
silybin
origin
pharmacolog
action
drug
could
help
therapi
viral
infect
pneumonia
natur
product
flavanoid
like
compound
major
compon
might
meaning
treatment
infect
target
although
sever
compound
could
bind
virtual
screen
studi
compound
found
bind
contact
surfac
complex
suggest
compound
inhibitor
enzym
activ
rather
inhibitor
driven
viru
infect
like
describ
recent
publish
research
select
compound
also
unabl
bind
contact
surfac
complex
actual
potenti
inhibitor
may
suitabl
use
drug
treat
infect
poor
prognosi
would
induc
inhibit
enzym
activ
consid
protect
factor
lung
injuri
target
difficult
find
direct
inhibitor
nondrugg
target
like
echannel
etc
current
popular
protac
technolog
may
good
strategi
degrad
protein
inhibit
viru
potenti
bind
compound
found
studi
target
might
good
start
point
spike
protein
found
one
compound
natur
hesperidin
target
bind
spike
rbd
human
howev
like
bind
compound
noninterfac
bind
compound
may
still
meaning
applic
consid
fusion
cov
membran
host
cell
membran
need
big
conform
chang
remain
spike
part
rbd
remov
small
molecul
bound
spike
time
may
interfer
refold
spike
therefor
inhibit
viral
infect
process
furthermor
small
molecul
target
part
spike
protein
may
good
start
point
design
protac
base
therapi
also
dock
exist
antivir
drug
target
analyz
possibl
target
antivir
drug
horizont
analyz
drug
may
interact
target
vertic
analyz
target
base
dock
result
found
complex
plpro
rdrp
helicas
echannel
spike
like
therapeut
target
antivir
drug
three
target
echannel
screen
antivir
drug
may
due
model
problem
flexibl
small
protein
partial
model
echannel
whether
screen
antivir
drug
realli
work
target
need
verif
also
recommend
applic
new
coronaviru
pneumonia
compound
target
predict
triphosph
nucleotid
product
remdesivir
remdesivirtp
compet
rdrp
substrat
atp
interfer
viral
rna
synthesi
dock
result
show
remdesivirtp
bind
rdrp
score
dock
result
consist
origin
antivir
mechan
think
remdesivir
may
good
treat
pneumonia
addit
remdesivir
also
predict
bind
human
protein
facilit
viru
infect
new
discoveri
provid
idea
subsequ
research
chloroquin
phosphat
shown
better
effect
recent
studi
drug
clear
target
action
dock
result
chloroquin
phosphat
predict
possibl
combin
echannel
need
experi
verifi
conclus
respons
recent
report
antiaid
drug
lopinavir
ritonavir
tablet
poor
effect
treatment
novel
coronaviru
pneumonia
toxic
side
effect
analyz
conjunct
dock
result
molecular
dock
result
show
ritonavir
possibl
target
echannel
lopinavir
possibl
target
helicas
nrbd
echannel
target
echannel
may
fals
posit
due
model
inaccuraci
small
flexibl
protein
partial
model
lopinavir
ritonavir
observ
possibl
bind
major
target
like
plpro
rdrp
dock
result
impli
lopinavir
ritonavir
tablet
may
suitabl
treatment
infect
result
entir
articl
base
comput
virtual
screen
conduct
vivo
vitro
antivir
experi
yet
want
share
result
scientist
research
soon
possibl
subsequ
research
tri
solv
threedimension
structur
protein
drug
complex
provid
target
inform
drug
intervent
longterm
drug
design
perform
vivo
vitro
evalu
candid
drug
obtain
studi
prepar
clinic
trial
applic
analysi
therapeut
target
